Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



New Products

Related to Applications of New Synthesis Technologies in Drug Discovery and Development

    • Gene-Editing Services
    • Cellectis bioresearch
    • Custom TALEN™ services can help researchers with gene-editing projects including gene knockout, gene tagging, promoter swapping, and nucleotide substitution. Project support managers can provide users with expertise to achieve customized cells and
    • Immunoassay Slide
    • QuantiScientifics
    • The A²® Oligo-Link-it slide is designed for the development of multiplex immunoassays. The plastic slide contains arrays of capture oligonucleotides covalently linked to the surface. Antibodies can then be oligo-linked to complementary ol
    • Gene-Expression Microarray
    • Agilent Technologies
    • The SurePrint G3 Human Gene-Expression v2 microarray is available with an array of probes designed using the Broad Institute’s human reference catalog of large intergenic noncoding RNAs. The microarray is part of a microarray platform with a range
    • Capture Oligonucleotides
    • Integrated DNA Technologies (IDT)
    • xGen™ Lockdown™ probes are individually synthesized 60–120 nucleotide 5’-biotinylated capture oligonucleotides designed to enable high-depth sequencing and analysis of specific regions of the genome. xGen Lockdown probes work well for target enrich
    • Single-Cell Gene Expression Assay
    • NanoString Technologies
    • A single-cell gene expression application is now available that can provide researchers with a flexible and sensitive approach to discovering differences in cell-to-cell gene expression profiles. The nCounter® Single-Cell Gene Expression assay
    • Cell-Line Customization Service
    • Cellectis bioresearch
    • Gene customization experts can modify cell lines at any gene, at any position. Services available include gene modification, knock-out, and targeted transgene integration. Thirteen years of genome customization expertise, TALEN™ technology, and IP
  • Page 1 of 1 (6 items) 1 

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll